Injectable Index
A product is more than its headline ingredient
Section titled “A product is more than its headline ingredient”Injectable Index connects material identity with physical form, carrier, presentation, preparation, intended use, regional approval, and the companies responsible for a product.
The reference begins with three connected areas: collagen stimulators, hyaluronic acid fillers, and fat-reduction injectables. All are organized around finished products rather than ingredient names alone.
Reference areas
Section titled “Reference areas”| Area | What it clarifies |
|---|---|
| Collagen Stimulators | How the four material groups fit together—and where the umbrella term stops being useful |
| Hyaluronic Acid Fillers | Why concentration, crosslinking, gel architecture, measurements, and regional identity must remain product-specific |
| Fat-Reduction Injectables | How approved DCA drugs, PPC/deoxycholate mixtures, cosmetics, and online-market products differ in formulation and regulatory status |
Current reference paths
Section titled “Current reference paths”Collagen stimulators
Section titled “Collagen stimulators”| Start with | What it clarifies |
|---|---|
| PLLA | Why Sculptra and Lanluma should remain product-specific despite sharing a polymer family |
| PDLLA | How AestheFill differs from hybrid PDLLA + HA products such as Juvelook |
| CaHA | How microspheres and carrier gel contribute different parts of the clinical presentation |
| PCL | Why Ellansé and Gouri cannot be interpreted from the material acronym alone |
The first product-level entries cover Sculptra, Lanluma, AestheFill, Juvelook, Radiesse, and Ellansé.
Hyaluronic acid fillers
Section titled “Hyaluronic acid fillers”Start with Formulation and Gel Architecture to identify the finished gel, then use Rheology and Physical Properties to judge whether laboratory measurements can be compared.
The first product-family entries cover Restylane, Juvéderm, Belotero, and the Teoxane RHA Collection.
Fat-reduction injectables
Section titled “Fat-reduction injectables”Start with Terminology and Mechanisms to separate deoxycholic acid drugs, deoxycholate salts, PPC mixtures, injection lipolysis, and Lipodissolve. Then use Product and Regulatory Classification to distinguish an approved medicine from a marketed solution, cosmetic, device claim, or unapproved injectable drug.
The initial product map covers Kybella / Belkyra, V-OLET, Rongzhi, Aqualyx, Lipo Lab, Kabelline, Dr. Lipo+, and Lemon Bottle.